BOULDER, Colo., Sept. 5, 2025 /PRNewswire/ — Foresight Diagnostics, a leader in ultrasensitive minimal residual disease (MRD) detection, today announced an oral presentation in partnership with University Health Network’s (UHN) Princess Margaret Cancer Centre at the IASLC 2025 World…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
